Bambusa Therapeutics
bambusatherapeutics.com
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$67.4M
3 rounds on record
Latest round
$53.3M
Venture round · Feb 2025 · 20 mo ago
Team
201-500
employees, estimated range
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 12, 2025
Raised a round Venture round $53.3M · SEC Form D
Jun 12, 2024
Raised a round Venture round $9M · SEC Form D
Jun 12, 2024
Raised a round Venture round $5.1M · SEC Form D
2024
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2025 | $53.3M | — | SEC Form D |
| Venture round | Jun 2024 | $5.1M | — | SEC Form D |
| Venture round | Jun 2024 | $9M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Bambusa Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Shanshan XuExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
Redefining Complement Therapies. Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for…
Driving immune-mediated therapeutic innovation for women. Freya focuses on the underlying drivers of disease, not just symptoms.
Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.
ABOUT US Our Mission To design and build engineered protein therapeutics with our AI-native platform, transforming what's possible in…
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory…
Overview
Advancing innovative therapies for immune-mediated diseases.. This page is strictly for career opportunities.
People
Shanshan Xu
Executive Officer, Director
Helmut Jeggle
Director
Sean Marett
Director
Derek DiRocco
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
200-500 est. staff